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Abstract: Glycation of proteins is a nonenzymatic process in which proteins react with reducing sugar molecules. This process takes
place at ε-amino (ε-NH+) groups of lysine or hydroxylysine residues as well as α-amino groups of N-terminal residues. In the present
study glycation of ε-NH+ groups of lysines was computationally analyzed for 26 proteins based on their 3D structures. We determined
the spatial relationship with acidic or basic residues and correlated them with the glycation prediction algorithm Netglycate 1.0 software,
which employed primary structure exclusively for glycation site prediction. Of the lysines from 19 of the 20 proteins employed to build
the Netglycate 1.0 algorithm 87.80% depicted a spatial relationship with acidic or basic residues. For the remaining seven proteins that
were not included in the algorithm, 95.23% of the lysines exhibited a spatial relationship with acidic or basic residues. For these seven
proteins, Netglycate 1.0 predicted only 52.38% of the lysines with a previously reported experimental glycation as potential glycation
sites. In all cases, distances between residues were less than or equal to 9.78 Å. These results suggest that it is the spatial relationship of
lysines with acidic or basic residues in the 3D conformation of a protein that determines the glycation target site, rather than a specific
sequence of the primary structure.
Key words: Glycation, lysines, Netglycate 1.0, 3D structure

1. Introduction
Protein glycation is a nonenzymatic process in which
proteins react with reducing sugar molecules. The initial
glycation reaction is reversible and occurs between aldehyde
or ketose groups in reducing sugars and free amino groups
in proteins (α amino of the N-terminal amino acid or
ε-NH+ of lysine or hydroxylysine residues). This reaction
results in the formation of aldimines or Schiff bases. These
unstable molecules are rearranged molecularly generating
compounds called Amadori products. In the second stage
of glycation, Amadori products are involved in a series of
irreversible reactions called Maillard reactions, resulting in
the formation of advanced glycation end products (AGEs).
Formation of AGEs involves dehydration reactions, cyclic
condensation, intermolecular crosslinks, and oxygen
free radical oxidation (Baynes et al., 1989). The process
* Correspondence: rpoutou@javeriana.edu.co, hsaenz@ucla.edu.ve
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may occur both extra- and intracellularly. Extracellular
glycation depends mainly on sugar concentration and
contact time between sugars and proteins. These events
are determined by the average life of each molecule (Casey
et al., 1995). Intracellularly the glycation process is more
complex due to the presence of multiple potential sources
of formation AGEs at the cytosolic metabolism level.
Glycation has been widely applied in the food industry
to improve food appearance and taste. It is also used in
cosmetics manufacturing (Uribarri et al., 2010). Although
glycation is recognized for its beneficial properties in
industry, glycation phenomena are also involved in
the cellular aging processes. This can lead to various
pathologies associated with complications resulting from
structure and/or function alterations that change the
bioactivity of a large number of proteins (Monnier et al.,
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1984; McCarthy et al., 1998; Verbeke et al., 2000; Zeng et
al., 2006; Bose et al., 2013; Suravajjala et al., 2013).
The lysine glycation of ε-amino groups found in 20
proteins, with reports of experimentally determined
glycation, has been statistically evaluated (Bo-Johansen
et al., 2006). Based on these results the authors proposed
a predictive algorithm for lysine glycation (www.cbs.
dtu.dk/services/NetGlycate
1.0).
Methodologically
they combined lysine glycation prediction probabilities
in 60 artificial neural networks, obtaining a Mathews
correlation coefficient of about 0.58. From their study they
concluded that amino acids, mainly glutamate and lysine
residues, catalyze the glycation of nearby lysines. Catalytic
acidic amino acids are mainly found C-terminally from
the glycation site, whereas basic lysine residues are mainly
found N-terminally (Bo-Johansen et al., 2006). It is
important to note that Netglycate, like other computational
predictors (Gupta et al., 1999; Julenius, 2007; Steentoft et
al., 2013), uses only the protein primary sequence and
computer-generated functional knowledge.
Many motifs have been studied in detail (Glusker,
1991; Copley and Barton, 1994; Fischer et al., 1994;
Wallace et al., 1997). However, only a few methods that
enable more general investigations into small motifs in
protein structures have been published (Erdin et al., 2011).
In general, there are two types of spatial motif recognition
techniques. In one, a motif is compared with a database
of structures; in the other, a database of motifs is scanned
against a structure. As the structural databases expand,
new methods are required to analyze protein structures.
For these reasons, continued progress in automated
annotation is imperative. This means increasing the
specificity and sensitivity of function predictions. This
paper describes an approach we developed that combines
motif prediction based on primary sequence with distance
geometry. The aims of this study were: 1) establish whether
there is a glycation pattern based in the spatial relationship
of glycated lysines, 2) identify potential glycation by
computational methods focusing on 3D structure, and 3)
correlate the results with experimental reports of glycation
and glycation-prediction by Netglycate 1.0.
2. Materials and methods
2.1. Analyzed proteins
We first analyzed a group consisting of 19 of the 20 proteins
used to develop the Netglycate 1.0 algorithm (except
for TAU, P10636) (Bo-Johansen et al., 2006). This first
group included bovine aA crystalline (P02470), bovine
aB-crystallin (P02510), bovine bB2-crystallin (P02522),
bovine gB-crystallin (P02526), bovine glutathione
peroxidase (P00435, EC 1.11.1.9), bovine MIP (P06624),
bovine RNPase (P61823, EC 3.1.27.5), human albumin
(P02768), human apolipoprotein A-1 (P02647), human
apolipoprotein E (P02649), human β2-microglobulin

(P61769), human bisphosphoglycerate mutase (P07738,
EC 5.4.2.4), human CD59 (P13987), human complement
factor B (P00751), human hemoglobin A (P69905), human
hemoglobin B (P68871), human superoxide dismutase
(P08294, EC 1.15.1.1), pig alanine aminotransferase
(P13119, EC 2.6.1.2), and rat aldehyde reductase (P51635,
EC 1.1.1.2).
Additionally, we included a second group of seven
proteins not considered by the authors in the development
of the Netglycate 1.0 algorithm. This second group
included bovine alkaline phosphatase (P19111, EC
3.1.3.1), bovine insulin (P01317), chicken ovalbumin
(P01012), pig aspartate aminotransferase (P00506, EC
2.6.1.1), human alcohol dehydrogenase (P00325, EC
1.1.1.1), human interferon γ (P01579), and human
iduronate 2-sulfate sulfatase (IDS) (P22304, EC 3.1.6.13),
the deficiency of which causes mucopolysaccharidosis
type II, also known as Hunter syndrome (OMIM 309900).
Within this seven-protein group we included human IDS
since it has been expressed by our group in E. coli and P.
pastoris (Córdoba-Ruiz et al., 2009; Landázuri et al., 2009;
Poutou-Piñales et al., 2010; Morales-Álvarez et al., 2013)
for employment in studies of enzyme replacement therapy
for Hunter syndrome. For this study all primary sequences
were extracted from Protein Knowledgebase (UniProtKB)
(The UniProt Consortium, 2012).
2.2. 3D Experimental structure retrieval
For this study we used 21 protein structures resolved
by X-ray crystallography or NMR and deposited in the
Protein Data Bank (PDB) (Table 1; Figure 1) (Berman et
al., 2003).
2.3. 3D Theoretical structure retrieval
Three-dimensional models of five proteins were employed,
and 3D models of four proteins were constructed by
homology modeling (Chen et al., 2014; Seddigh and
Darabi, 2014) with the assistance of the protein-modeling
tools ProMod and Swissmodel (Peitsch, 1996). In contrast,
a previously developed 3D model was employed for IDS
(Figure 1) (Sáenz et al., 2007). There are two reasons to
expect that this approach could produce realistic models.
First, 3D models based on crystallization and available
structural-resolution studies are used as templates (Table
2). Second, all selected proteins share a set of conserved
structural elements. The modeling was performed as
follows. First, the complete protein sequences of the
proteins were screened against the PDB in order to identify a
template structure appropriate for modeling. From a series
of templates, we selected the three-dimensional models for
bovine alkaline phosphatase, pig alanine aminotransferase,
pig aspartate aminotransferase, and rat aldehyde reductase.
The multiple sequence/structure alignment generated
during the first attempt and the ProMod command files
were resubmitted for refinement of the primary model
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Table 1. Proteins employed in this study with 3D structure obtained experimentally.
UniProt ID/AC

PDB ID

Method

X-ray
resolution (Å)

CRAA_BOVIN (P02470)

3L1F

X-ray

1.15

CRAB_BOVIN (P02510)

2WJ7

X-ray

2.63

CRBB2_BOVIN (P02522)

1BLB

X-ray

3.30

CRGB_BOVIN (P02526)

1AMM

X-ray

1.20

GPX1_BOVIN (P00435)

1GP1

X-ray

2.00

INS_BOVIN (P01317)

1APH

X-ray

2.00

MIP_BOVIN (P06624)

1YMG

X-ray

2.24

RNAS1_BOVIN (P612823) 1

3MZR

X-ray

1.50

ALBU_HUMAN (P02768)

1AO6

X-ray

2.50

ADH1B_HUMAN (P00325)

1DEH

X-ray

2.20

APOA1_HUMAN (P02647)

1AV1

X-ray

4.00

APOE_HUMAN (P02649)

1B68

X-ray

2.00

B2MG_HUMAN (P61769) 2

2YXF

X-ray

1.13

PMGE_HUMAN (P07738)

1T8P

X-ray

2.50

CD59_HUMAN (P13987)

1CDQ

NMR

-

CFAB_HUMAN (P007510)

1DLE

X-ray

2.10

HBA_HUMAN (P69905) 3

1Z8U

X-ray

2.4

HBB_HUMAN (P68871)

4

1DXT

X-ray

1.7

IFNG_HUMAN (P01579)

1EKU

X-ray

2.90

SODE_HUMAN (P08294)

2JLP

X-ray

1.70

OVAL_CHICK (P01012)

1UHG

X-ray

1.9

Data were extracted from UniProtKB (The UniProt Consortium, 2012) and PDB (Berman et al., 2003).
= Replaces P00656, 2 = replaces P01884, 3 = replaces P0192, 4 = replaces P02023.

1

by energy minimization with CHARMM (Peitsch, 1996).
To make a comparison among structures, we performed
multiple structural alignment with the software, Visual
Molecular Dynamics (VMD). VMD is designed for the
visualization and analysis of biological systems. VMD can
read standard Protein Data Bank (PDB) files and display
the contained structure (Humphrey et al., 1996; Barragan
et al., 2015; Hardy et al., 2015).
2.4. Potential glycation site computational prediction
For lysine residue glycation site prediction, the primary
sequence was used and analyzed by Netglycate 1.0
algorithm. To estimate the uncertainty grade in the
atomic positions from the selected proteins, the lysine
distances from the ε-NH+ group to the free acid group of
the side chain of the acid residues, namely the γ-COOH
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group of glutamate or β-COOH of aspartate, respectively,
were calculated. Distance of lysine to basic residues was
calculated from the ε-NH+ to the basic groups of the
side chain of the basic residues: the imidazole group of
histidine, the guanidino group of arginine, or ε-NH+ of
lysine, respectively. Distances between lysine (K) and
other acid or basic amino acids (Tables 3 and 4; Figure 2)
were measured with SPDBV 4.1.
3. Results
In order to tackle glycation site analysis by structurebased methods, we predicted a homology model due to
the absence of X-ray crystallographic data of selected
proteins. Global Qmean scores of each generated model
were obtained to assess model qualities, and energy
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Figure 1. Representation of 3D structures. A: Pig aspartate aminotransferase (EC 2.6.1.2; UniprotKB AC:
P13119, PDB ID: AATM-PIG; constructed by homology modeling for this study). B: Human iduronate 2-sulfate
sulfatase (EC 3.1.6.13; UniprotKB AC: P22304, PDB ID: IDS_HUMAN; model developed by Sáenz et al., 2007).
C: Human alcohol dehydrogenase (EC 1.1.1.1; UniprotKB AC: P00325; PDB ID: 1DEH).

Table 2. Data templates for constructed structures 3D by homology modeling of proteins 166 employed in this study.

UniProt ID/AC

Template

Sequence
identity (%)

Residue
range

X-ray
resolution (Å)

RMSD
(Å)

Number of
residues in
favored region

Number of
residues in
allowed region

Number of
residues in
outlier region

PPBI_BOVIN (P19111)

1ew2A

76

20–498

1.82

1.2

(96.2%)

(3.4%)

(0.4%)

ALAT1_PIG (P13191)

3IHJ

80

1–20

2.3

2.3

(95.9%)

(3.5%)

(0.6%)

AATM_PIG (P00506)

7aatA

87

30–430

1.90

1.4

(97.5%)

(2.5%)

(0.0%)

AKA1_RAT (P51635)

2ao0A

93

3–325

1.85

1.6

(98.5%)

(1.5%)

(0.0%)

IDS_HUMAN ( P22304)

1e33

42

38–103

2.50

0.8

(87.5%)

(9.4%)

(3.1%)
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minimization procedure was performed to optimize
conformations and side chain rotamers. Energy
minimization allows us to examine the local minimum
around the predicted conformations. The resulting models
were then evaluated by Qmean score and global RMSD.
Assessments of protein models for stereo chemical quality
are shown in Table 2.
For this study we did not consider K10 glycation in
bovine B2 crystalline, since the tertiary structure employed
begins with residue 14. Thus, we only analyzed 99% of the
lysines (82/83). For 87.80% (72/82) out of the 19 proteins
with lysine reported, a close spatial relationship with a

glutamate residue (E) or aspartate (D) was observed, with
distances ≤9.72 Å. For the remaining 10 glycated lysines
(12.2%) four (4.78%) of them had another adjacent basic
residue such as arginine (R), histidine (H), or K in the
primary sequence; and three (3.57%) showed very close
yet noncontiguous arginine residue. The remaining two
lysines (2.42%) demonstrated a spatial relationship with
another lysine or histidine distant in the primary sequence
but close in the tertiary structure (Table 3). It was only in
the last 10 lysines (1.21%), K67 bovine bB2 crystalline,
that an explanation for glycation proximity of lysines with
basic or acidic amino acids within the 3D structure of the

Table 3. Spatial relationship between glycated lysine and acidic or basic residues in the tertiary structure for proteins used in developing
the Netglycate 1.0 algorithm.
Protein
UniprotKB (AC)
Bovine αA crystallin
CRAA_BOVIN (P02470)
Bovine αB crystallin
CRAB_BOVIN (P02510)

Primary sequence

Glycated lysine (K) and
3D structure distance (Å) to acidic
or basic residue

QHPWFKRTLGP

*

IFLDVKHFSPE

K78–D76: 4.55

SPEELKVKVLG

K90–E87: 9.58

EELKVKVLGDV

K92–E99: 5.97

HQTQAGKPQPLN
ETGVEKAGSVL
EQANCKGEQFV

References
(Abraham et al., 1994)
(Abraham et al., 1994)

K10: No available residue
in the 3D structure
K47–D91: 4.16
K67: Undetermined
in this study

EQFVFEKGEYPR

K75–K17: 8.73**

SLRPIKVDSQE

K100–R97: 7.18**

DSQEHKIILYE

K107–E122: 3.42

PNFTGKKMEII

K119–E138: 4.20

NFTGKKMEIID

K120–E122: 4.73

HGYQEKVSSVR

K139–E112: 5.79

QYLLEKGDYKD

K167–D169: 9.27

EKGDYKDSSDF

K171–D169: 5.37

Bovine ϒB-crystallin
CRGB_BOVIN (P02526)

GKITFYE

K2–E17: 3.28

(Casey et al., 1995; Smith et
al., 1996)

Bovine glutathione peroxidase
GPX1_BOVIN (P00435)

EVNGEKAHPLF

K117–E112: 7.15

(Baldwin et al., 1995)

LFPRLKSVSER

K228–D220: 6.58

RLSILKGSRPS

K238–R241: 9.08**

EPVELKTQAL

K259–E257: 9.72

KETAAA

K1–E2: 8.73

ETAAAKFERQH

K7–E2: 5.81

CNQMMKSRNLT

K37–D38: 7.84

TKDRCKPVNTF

K41–R39: 5.88**

Bovine βB2-crystallin
CRBB2_BOVIN (P02522)

Bovine MIP
MIP_BOVIN (P06624)

Bovine ribonuclease pancreatic
RNAS1_BOVIN (P61823)

16

(Zhao et al., 1996)

(Swamy-Mruthinti and Schey,
1997)

(Watkins et al., 1985; Cotham
et al., 2003)
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Table 3. (Continued).
VAHRFKDLGEE
VTEFAKTCVAD
EETFLKKYLYE
FAKRYKAAFTE
KQRLKCASLQ
SQRFPKAEFA
FAEVSKLVTDL
ISSKLKECCEK
ECCEKPLLEK
DFVESKDVCKN
NYAEAKDVFLG
SKDVCKNYAEA
LLRLAKTYETT
VFDEFKPLVEE
VRYTKKVPQV
GSKCCKHPEAK
KHPEAKRM PCA
ERQIKKQTALV
LVELVKHKPKA
LVKHKPKATK
TKEQLKAVMDD
FAEEGKKLVAA

K36–E81: 6.33
K75–E40: 3.78
K161–E61: 7.03
K186–E155: 4.53
K223–E316: 8.86
K249–D320: 4.51
K257–D261: 4.40
K300–E304: 5.14
K305–E301: 6.1
K337–D338: 6.23
K347–E378: 4.96
E341–D338: 4.33
EK375–E378: 6.61
K402–E406: 5.42
*
K463–E420: 9.21
K468–E318: 7.6
K549–E542: 7.45
K558–E555: 5.71
*
K569–D573: 5.67
*

ELKAYKSELEQ

K93–E97: 4.90

(Shuvaev et al., 1999)

EEYTKKLNTQ

K263–E259: 4.65

(Calvo et al., 1993)

PAENGKSNFLN
EVDLLKNGERI
GERIEKVEHSD
DLSFSKDWSFY
TLSQPKIVKWD
QPKIVKWDRD

K39–E36: 5.39
K61–D96: 3.93
K68–E70: 8.9
K78–D79: 7.64
K111–H104: 9.19**
K114–E97: 6.14

(Fujita et al., 1998)

SKYKLI

K2–E223: 4.92

SKYKLIML

K4–E220: 6.61

EGAWNKENRFC

K17–E32: 6.45

ARNCGKQLKAL

K42–E72: 4.08

RSESLKDVLER

K158–E162: 4.11

SRALLKHLEGI

K196–E204: 6.88

Human CD59
CD59_HUMAN (P13987)

WNKCTKFEHCN

K41–D22: 4.73

(Acosta et al., 2000)

Human complement factor B
CFAB_HUMAN (P007510)

FTGAKKCLVNL

K291–E462: 4.97

(Niemann et al., 1991)

VLSPADKTNVKA

K7–D74: 3.89

KAAWGKVGAHA

K16–E116: 4.96

VKGHGKKVADA

K61–D64: 8.51

HASLDKFLASV

K127–D6: 4.97

STVLTSKYRVHL

K139–D85: 5.12

Human albumin
ALBU_HUMAN (P02768)

Human apolipoprotein E
APOE_HUMAN (P02649)
Human apolipoprotein A-1
APOA1_HUMAN (P02647)

Human β2-microglobulin
B2MG_HUMAN (P61769)

Human bisphosphoglycerate
mutase PMGE_HUMAN
(P07738)

Human hemoglobin A HBA_
HUMAN (P69905)

(Garlick and Mazer, 1983;
Shaklai et al., 1984; Iberg and
Fliickiger, 1986; Lapolla et al.,
2004)

(Miyata et al., 1994)

(Shapiro et al., 1980; Zhang et
al., 2001)
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Table 3. (Continued).

Human hemoglobin B HBB_
HUMAN (P68871)
Human superoxide dismutase
SODE_HUMAN (P08294)
Pig alanine aminotransferase
ALAT1_PIG (P13191)
Rat aldehyde reductase
AKA1_RAT (P51635)

LTPEEKSAVTA

K9–D80: 9.4

TALWGKVNVDE

K18–E120: 4.85

KAHGKKVLGAF

K66–D22: 3.88

AHHFGKEFTPP

K121–E122: 8.77

EHSERKKRRR

K211–E216: 9.52

HSERKKRRRES

K212–E218: 9.16

FHSVSKGFMG

K11–E16: 3.85

SVGAGKAV PRE

K67–E61: 8.37

K LWNTKHHPED

K84–D121: 5.78

DSTHYKETWKA

K140–D170: 3.80

EALVAKGLVKA

K153–E92: 3.95

(Shapiro et al., 1980; Zhang et
al., 2001)

(Adachi et al., 1992)
(Beranek et al., 2001)

(Takahashi et al., 1995)

* = Presence of another adjacent basic residue in the primary sequence.
** = Presence of a basic residue near the primary sequence or in the tertiary structure.

B

A

C

D

Figure 2. Distance between lysine (LYS) and amino acids (ASP = aspartate or GLU = glutamate) measured in Å for sites where glycation
has been experimentally demonstrated. A: Bovine alkaline phosphatase LYS75-ASP354 (EC 3.1.3.1; UniprotKB AC: P19111, PDB ID:
PPBI-BOVIN; constructed by homology modeling for this study). B: Bovine g-crystallins LYS2-GLU17 (UniprotKB AC: P02526; PDB
ID: 1AMM). C: Pig alanine aminotransferase LYS11-GLU16 (EC 2.6.1.2; UniprotKB AC: P13119, PDB ID: ALAT1-PIG; constructed by
homology modeling for this study). D: Chicken ovalbumin LYS369-GLU231 (UniprotKB AC: P01012; PDB ID: 1UHG).

18

SÁENZ-SUÁREZ et al. / Turk J Biol

protein was not found. In these cases, distances were also
≤9.08 Å (Table 3; Figure 2).
Regarding the group of seven proteins that were not
taken into account for the development of the Netglycate 1.0
algorithm (Table 4), we found that there are experimental
glycation reports for only five of them (71.4%). These

proteins have 21 lysines, and only 11 (52.38%) of them are
predicted by Netglycate 1.0 as potential glycation sites. In
this case a 3D structure exists with a spatial relationship
between acidic residues (D or E) for 20 of the 21 lysines
(95.23%). The remaining lysine (4.77%) establishes a
spatial association with an arginine residue. The maximum

Table 4. Spatial relationship between glycated lysine and acidic or basic residues in the tertiary structure for proteins not used in developing the Netglycate 1.0 algorithm.
Protein
UniProt ID (AC)

Bovine alkaline phosphatase
PPBI_BOVIN (P19111)

Bovine insulin
INS_BOVIN (P01317)

Chicken ovalbumin
OVAL_CHICK (P01012)

Human alcohol dehydrogenase
ADH1B_HUMAN (P00325)

Human interferon-ϒ
IFNG_HUMAN (P01579)
Human IDS
IDS_HUMAN (P22304)

Pig aspartate aminotransferase
AATM_PIG (P00506)

NetGlycate 1.0
prediction

Glycated lysine (K) and 3D structure
distance (Å) to acidic or basic residue

Yes

K75–D354: 4.84

Yes

K100–E473: 3.79

Yes

K141–D196: 9.78

Yes

K247–D190: 6.79

Yes

K303–E235: 3.43

Yes

K400–D427: 6.31

Yes

K28–E33: 8.73

No

K46–E116: 8.83

Yes

K55–R58: 8.89**

Yes

K61–D60: 7.95

No

K92–D85: 8.75

No

K122–E123: 7.16

Yes

K181–E333: 5.69

Yes

K189–E191: 5.49

Yes

K206–E204: 9.02

Yes

K226–E248: 5.12

No

K277–D350: 3.88

Yes

K279–D350: 7.65

No

K369–231: 4.46

Yes

K10–D25: 4.18

No

K39–E74: 8.44

No

K231–E234: 4.13

No

K248–E252: 6.65

Yes

K325–E154: 5.84

Yes

K109–E113: 6.69

No

K131–E120: 6.47

No

K124–D334: 7.00

No

K135–D45: 4.0

No

K164–E163: 7.06

No

K169–D46. 5.85

No

K227–D98: 8.00

No

K258–D222: 9.11

References

(McCarthy et al., 1998)

(Guedes et al., 2009)

(Huang et al., 2013)

(Shilton and Walton, 1991)

(Mironova et al., 2001)

No report

(Boušová et al., 2012)

** = Presence of other nearby basic residue in the primary sequence or in the tertiary structure.
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distance found between lysine and acidic or basic amino
acids in this group of proteins was 9.78 Å.
Within the second group of seven proteins that were
not considered for the Netglycate 1.0 original algorithm
construction, we included bovine alkaline phosphatase.
This protein is known experimentally to undergo
glycation. However, it is unknown which of the lysines
undergoes this modification (McCarthy et al., 1998).
In this study it was shown that all lysines in alkaline
phosphatase have the potential to be glycated (Table 4).

For human IDS, there are still no glycation experimental
reports. In this enzyme, lysines 124, 135, 164, 169, and 227
showed distances from acid residues ≤8.0 Å (Table 4).
Considering
glycation
promotes
protein
fragmentation, and it occurs at the glycated tag
(Mironova et al., 2001; Mironova et al., 2003), Table
5 shows the results of the theoretical fragmentation
of human recombinant IDS (hrIDS), as it would be
obtained when expressed in E. coli (Poutou-Piñales et al.,
2010; Morales-Álvarez et al., 2013).

Table 5. Theoretical possible fragments resulting from the fragmentation of hrIDS expressed in E. coli
or P. pastoris due to random glycation influence events on lysines 124, 135, 164, 169, and 227 (seen on
the 3D structure).
Theoretically suggested
fragments

Theoretical molecular weight
(kDa without glycosylation)

1–124

13,686.85

1–135

14,138.46

1–164

18,138.46

1–169

18,774.13

1–227

25,066.34

34–124

10,292.69

34–135

11,459.00

34–164

14,744.90

34–169

15,380.17

34–227

21,672.17

34–455*

47,403.72

455–550

11,093.72

124–135

1,312.50

124–164

4726.17

124–169

5361.84

124–227

17,308.19

135–164

3559.86

135–169

4195.53

135–227

16,141.37

164–169

781.86

164–227

7074.07

169–227

6438.39

124–455

43,247.80

135–455

42,081.00

164–455

33,013.68

169–455

32,378.01

227–445

25,957.63

*Mature form of protein.
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4. Discussion
Discovering sequence motifs or repeated patterns is of
great biological importance because identification can
lead to determination of function and elucidation of
evolutionary relationships among sequences. Research on
protein sequences revealed that specific sequence motifs
in biological sequences exhibit important characteristics
that act as catalytic sites or regions involved in molecule
binding. Identification of sequence motifs using
experimental methods is not possible, because often
sequences do not share a global sequence similarity (Erdin
et al., 2011). In addition, there is an exponential rise in
the volume of sequences in databases. For these reasons,
continued progress in automated annotation is imperative.
This means increasing the specificity and sensitivity of
function predictions.
Results from this study using the 3D structures of
proteins employed in developing the Netglycate 1.0
algorithm (Table 3) suggest that it is not a sequence in
the primary structure that is the main factor for lysine
glycation. Nonetheless, the spatial relationship in the
3D structure it is the main factor associated with lysine
glycation. In general, amino groups with the lowest pKa
value should be more reactive, favoring glycation, due to
their nucleophilic ability (Bunn et al., 1979). For lysines,
chemical properties of nearby residues in a protein primary
structure or 3D structure play a critical role in facilitating
or hindering lysine glycation (Iberg and Fliickiger, 1986;
Baynes et al., 1989; Shilton and Walton, 1991; Acosta et
al., 2000). It has also been suggested that the proximity
of an acid to a lysine residue catalyzes the formation of
Amadori products, which would make the lysine reactive
and, therefore, more susceptible to glycation (Baynes et
al., 1989). The acid residue in all cases has partial charges
regardless of whether the total net charge is null or has a
given value at different pH levels. Nevertheless, the results
shown here correspond to neutral pH, which is closely
maintained in all cellular and intercellular fluids in the
Earth’s living organisms. Furthermore, distances between
lysines and acid residues or other basic residues were ≤9.72
Å for all studied cases.
Of all proteins analyzed, 87.80% of the lysines displayed
distances to acidic residues ≤9.72 Å. In contrast, 9.56%
were close to another basic amino acid in the primary
sequence or the tertiary structure. As a consequence there
is a decrease in pKa, resulting in glycation in these latter
cases. Only the glycation of lysine K67 in B2 crystalline
(1.21%) did not meet the spatial relationship analysis
criteria used in this study (Table 3; Figure 2).
Analysis of the other proteins not used for algorithm
construction (Table 4; Figure 2) demonstrated the
following: 95.23% (20/21) of the lysines with data showing
experimental glycation have spatial relationships with
acidic residues in their tertiary structures, and a much

lower percentage had this association with a basic residue
4.77% (1/21). For this second protein group Netglycate 1.0
was able to predict glycation sites for only 52.38% (11/21)
of the lysines. These results support our hypothesis that 3D
structure spatial relationship is the determining factor in
lysine glycation, and not a specific sequence at the primary
structure, in the case of the globular proteins used in this
study. Based on our analysis we recommend such studies
to be performed on proteins that are thought to undergo
glycation.
Our group has reported human recombinant IDS
(hrIDS) production in E. coli (Córdoba-Ruiz et al.,
2009; Landázuri et al., 2009; Poutou-Piñales et al., 2010;
Morales-Álvarez et al., 2013). IDS is a hydrolase, and
it acts on sulfate ester bonds catalyzing the hydrolysis
of sulfate at C2 position in L-iduronic acid in dermatan
and heparan sulfate (Neufeld and Muenzer, 2001). To
maintain its biological activity, as with other sulfatases,
IDS requires posttranslational conversion of cysteine at
position 84 (C84) to 2-amino-oxoproic or 3-formylglycine
(Dierks et al., 2009). During IDS recombinant expression
and subsequent purification process, we observed a brown
mucilaginous formation on the ultrafiltration membrane
(Sáenz, 2005). We speculated on this byproduct, and
due to its similarity in appearance, it could be an
Amadori product. It is likely that Amadori products
formed from extract containing nondegraded medium
components. In addition, cells could have secreted and/
or excreted components during growth in the presence
of carbohydrates. We suggest Amadori products formed
from E. coli-produced hrIDS as a result of a glycation
process during crude extract storage at 4 °C.
It has been previously proposed that fragmentation
and aggregation of recombinant proteins expressed in E.
coli are associated with protein glycation (Mironova et al.,
2001, 2003). In human recombinant interferon gamma
(hrIFN-γ) the authors reported degradation despite
purification, homogenization, and maintenance in the
free protease of medium. In this work hrIFN-γ acted as a
glycated protein capable of undergoing cross-linking and
progressive fragmentation processes.
For the hrIDS 3D structure, lysines at positions 124,
135, 164, 169, and 227 presented distances to acidic
residues ≤8.0 Å. Although these sites were not identified
as potential glycation sites by Netglycate 1.0, distances
are within the range of proteins with experimentally
demonstrated glycation used in this study. In previous E.
coli–hrIDS expression reports by our group, SDS-PAGE
and Western-blot results identified different molecular
weights (MWs). For the recombinant protein these
ranged between 40 and 97 kDa (Poutou-Piñales et al.,
2010; Morales-Álvarez et al., 2013). These distinct forms
were different in MW compared to glycosylated enzyme
isolated from human tissues.
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We suggest that MW diversity detected in the hrIDS
expressed in E. coli may be the result of glycation events
as well as proteolytic. Consequently, the protein may
have been further fragmented. In addition, some of these
fragments could have aggregated, giving a rise to the
various sizes that were detected by western blot (PoutouPiñales et al., 2010; Morales-Álvarez et al., 2013).
Authors have found four types of proteases in Pichia
pastoris: carboxypeptidase Y, aminopeptidase, proteinase
A (PrA), and proteinase B (pRb) (Sinha et al., 2005). The
first of these enzymes hydrolyzes the peptide bonds at
the C-terminal and the aminopeptidase hydrolyzes at the
N-terminal, while the PrA enzyme acts on the sequences
LL-/-VY, PrB enzyme having a trypsin-like proteolytic
activity. During ultrafiltration processes of IDShr crude
extract, smaller 30 KDa fractions that showed catalytic
activity were obtained, which could explain the presence
and action of proteases (Poutou-Piñales et al., 2010).
In connection with this, the proteolytic activity of
carboxypeptidase and aminopeptidase does not generate
smaller fragments, nor do they exist within the hrIDS,
target sequences for PrA enzyme activity. Moreover,
proteolysis by pRb may generate a diversity of fragments
found between the following:
Fragment 1:
P S L G C YG D K LV R S P N I D Q L A S H S L L F Q NAFA Q QAVC A P S RVS F LT G R R P D T T R LY D F N S YW RV HAG N F ST I P QY K E NG Y V TM S VG K V F H PGISSNHTDDSPYSWSFPPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKMKTSAS PFFLAVGYHKPHIPFR,
Fragment 2:
LVRSPNIDQLASHSLLFQNAFAQQAVCAPSRVSFLTGRRPDT TRLYDFNSY WRVHAGNFSTIPQYFKENGYVTMSVGKVFHPGISSNHTDDSPYSWSFPPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKMKTSASPFFLAVGYH
KPHIPFR,
Fragment 3:
VSFLTGRRPDTTRLYDFNSYWRVHAGNFSTIPQYFKENGYVTMSVGKVFHPGISSNHTDDSPYSWSFPPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKMKTSASPFFLAV
GYHKPHIPFR,
Fragment 4:
R P D T T R LY D F N S Y W R V H A G N F S T I P Q YFKENGYVTMSVGKVFHPGISSNHTDDSPYSWSFPPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKMKTSASPFFLAVGYHKPHIPFRYPK,
Fragment 5:
LYDFNSYWRVHAGNFSTIPQYFKENGYVTMSVGKVFHPGISSNHTDDSPYSWSFPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKM KTSASPFFLAVGYHKPHIPFRYPKEFQ.
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The above fragments are smaller than 30 kDa and
have all six of the nine residues comprising the active
site of the enzyme. The literature reports four mutations
in which the hIDS is incomplete: E177-final, L213-final,
Y103-final, and R433-final, and phenotypes correspond
to moderate or intermediate presentations of the disease
in Hunter patients. This means that these mutant proteins
exhibit biological activity. Except for R433-final fragment,
the protein fragments have small molecular weights and
retain six of the nine amino acids of the active center,
suggesting fragments could be generated by pRb enzyme
activity during fermentation and that this enzyme could
be responsible for the catalytic activity detected.
Our theoretical fragmentation proposal (Table 5) can
be supported by the following data. First, western-blot
analysis confirms the presence of distinct hrIDS sizes
(Poutou-Piñales et al., 2010; Morales-Álvarez et al., 2013).
Second, biological activity found in the recombinant
protein shows C84 transformation to FGly (Poutou-Piñales
et al., 2010; Morales-Álvarez et al., 2013). Third, biological
activity found in different fractions of hrIDS expressed in
E. coli during its purification process highlights activity
found in the fraction with a MW lower than 30 kDa
(Poutou-Piñales et al., 2010). This experimental finding
is largely supported by the presence of C84-containing
fragments that have MWs that vary experimentally, most
likely due to molecular interactions during the glycation
process (Table 5).
In conclusion, the results from this study suggest
that glycation processes must be considered depending
on the lysine spatial relationship between basic or acidic
amino acids. These results support our hypothesis that 3D
structure spatial relationship is the determining factor in
lysine glycation, and not a specific sequence at the primary
structure, in the case of the globular proteins used in this
study.
In our hrIDS analysis, the different MWs found in E.
coli-expressed enzyme could be due to events resulting
from glycation and extracellular proteolytic activity,
which would result in fragmentation and intermolecular
aggregation, leading to protein fragment generation
(biologically active or not) with unpredictable MW.
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